Skip to content
healthcare.dev

Tizanidine

NDC 43063-868, Tizanidine, tablet, from PD-Rx Pharmaceuticals, Inc..

Product NDC
43063-868
Status
Listed
Labeler
PD-Rx Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091283
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43063-868 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIZANIDINE HYDROCHLORIDE2 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
43063-868-124306308681212 TABLET in 1 BOTTLE, PLASTIC (43063-868-12)
43063-868-304306308683030 TABLET in 1 BOTTLE, PLASTIC (43063-868-30)
43063-868-604306308686060 TABLET in 1 BOTTLE, PLASTIC (43063-868-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/615dfd5c-125a-40e2-a6da-afacde305282

Use it

Look up 43063-868 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43063-868 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43063-868. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.